• Nenhum resultado encontrado

Arq. NeuroPsiquiatr. vol.58 número4

N/A
N/A
Protected

Academic year: 2018

Share "Arq. NeuroPsiquiatr. vol.58 número4"

Copied!
5
0
0

Texto

Imagem

Table 1. Efficacy outcomes of the placebo and clonazepam groups.
Table 2. Adverse effects reported by the patients of the clonazepam and placebo groups.

Referências

Documentos relacionados

Lipsitz et al 6 retrospectively evaluated the presence of separation anxiety disorder in patients with social phobia, panic disorder and obsessive-compulsive disorder and showed

In a previous study, 14 we found a high psychiatric morbidity (61.6%) in a sample of 90 asthmatic patients, mainly panic disorder/agoraphobia spectrum disorders (40.7%),

The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for

In the multicenter, randomized PIVENS (Study of Pioglitazone versus Vitamin E versus Placebo for the Treat- ment of Non-Diabetic Patients with Hepatic Steatosis) study, 247

most of panic disorder patients... to genetic predisposition to panic disorder. In addition, CO 2 hypersensitivity might represent the phenotypical expression of

This multicenter, double-blind placebo-controlled trial randomized 628 patients with a baseline International Index of Erectile Function (IIEF) score of >26 into taking nightly

This double-blind, randomized, placebo-controlled clinical trial is the irst study to evaluate the toxicology and safety of tincture of O. alata in patients with

To determine if a ten days treatment with clonazepam attenuates the panic attacks induced by the inhalation of 35% carbon dioxide in panic disorder.. METHOD: We randomly selected